Atossa Therapeutics (ATOS) Stock Price, Quote, News & History | Benzinga

Atossa Therapeutics Inc (ATOS) Stock Price, Quote, News & History

ATOSNASDAQ

Trade with Public

Trade with Public

$2.54

-0.05-1.93%

At close: Aug 21, 5:00 PM EST

$2.56

0.0240.94%

After Hours: Aug 21, 4:08 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.59

Close

$2.54

Volume / Avg.

25.66K / 154.00K

Day Range

$2.51 - $2.62

52 Wk Range

1.70 - 19.35

Market Cap

$25.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

7.62%

Days to Cover

13.48

Recent Atossa Therapeutics Inc News

Crude Oil Edges Higher; Driven Brands Posts Upbeat Earnings

US stocks rise with Nasdaq up 150 points. Dow up 0.54%, Nasdaq up 0.63%, S&P 500 up 0.26%. Industrials and Enliven Therapeutics lead gains. Dana Inc and Oracle Corp down. Oil up 0.7%, gold down 0.7%. European and Asian markets mixed. Initial jobless claims and producer prices higher than expected.

Avi Kapoor

Dow Jumps Over 250 Points; US Initial Jobless Claims Rise

US stocks up, Dow gains 250 pts. Dow up 0.58% while NASDAQ up 0.67%. Materials shares jump 1.5%, communication services down 1.3%. Jobless claims up.

Avi Kapoor

Why Are Shares Of Atossa Therapeutics Up Today?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock is trading higher on Thursday. Here's what investors need to know.

Alex Perry

This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-35.77M

Investing Cash Flow (TTM)

-14.00K

Financing Cash Flow (TTM)

4.02M

Free Cash Flow (TTM)

-35.78M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-31.76M

Analyst Trends and Forecast

1

Mar

1

Apr

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$846.38K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.96

Earnings Yield % (TTM)

-167.57%

Earnings Yield % (FWD)

-148.26%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.69

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$26.09M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.59

Close

$2.54

Volume / Avg.

25.66K / 154.00K

Day Range

$2.51 - $2.62

52 Wk Range

1.70 - 19.35

Market Cap

$25.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

7.62%

Days to Cover

13.48

About

Sector

Health Care

Industry

Biotechnology

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Atossa Therapeutics (ATOS) stock?

A

You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Atossa Therapeutics (ATOS) competitors?

A

Other companies in Atossa Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Atossa Therapeutics (ATOS) stock?

A

Atossa Therapeutics has a consensus price target of $16.25.

Q

What is the current price for Atossa Therapeutics (ATOS)?

A

The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $2.564 last updated August 21, 2026 at 4:08 PM EDT.

Q

Does Atossa Therapeutics (ATOS) pay a dividend?

A

There are no upcoming dividends for Atossa Therapeutics.

Q

When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?

A

Atossa Therapeutics does not have any upcoming earnings scheduled.

Q

Is Atossa Therapeutics (ATOS) going to split?

A

There is no upcoming split for Atossa Therapeutics.

Q

What sector and industry does Atossa Therapeutics (ATOS) operate in?

A

Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.